Drug · DIN 02279991
VFEND
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 17, 2008; first marketed July 17, 2008.
- Drug Identification Number (DIN)
- 02279991
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Voriconazole J02AC03
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VORICONAZOLE | 200 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 15, 2006: NOC 7960Supplement to a New Drug Submission (SNDS) · New dosage form
Other DINs named VFEND
- DIN 02256460 · Marketed
- DIN 02256479 · Marketed
- DIN 02256487 · Marketed